The international point-of-care fentanyl test kit market is expected to hit $180.9 million by 2033, with a compound annual growth rate of 5.5% during the forecast period.
The market was most recently valued at $105.4 million in 2023, according to a Jan. 2 news release from Future Market Insights. The United States market is expected to reach $61.8 million by 2033, with a compound annual growth rate of 6%.
FMI attributed the growth to the increased prevalence of fentanyl abuse around the world, in addition to growing harm reduction efforts and government regulations emphasizing fentanyl testing in places like addiction treatment centers and emergency settings, the release said.